FZD4 and myeloid sarcoma: Multiple sclerosis (MS) results from an immune attack by infiltrating inflammatory leukocytes in the central nervous system, causing hard, mottled pathologic changes and nerve conduction disorders.372,373 At present, medication aims to control GPCR-regulated immune cell function as one of the treatment regime for MS.